Your Plumber Offers A Money-Back Guarantee. Should Your Doctor?
Even though consumers don’t expect to pay for faulty service or goods, they are often forced to pay for bad health care. But a small number of hospitals and doctors are seeking to change that practice.
‘I’ve Never Been This Busy’: As Marketplace Deadline Nears, Navigators Feel The Pinch
With less federal funding and marketing, local groups are feeling the pressure to keep up enrollment in the plans offered through the federal health law’s marketplace.
Parents Are Not Liable For Medical Debts Of Adult Children On Shared Insurance
Even though the federal health law allows young adults to stay on their parents’ plan, those children are generally responsible for their own debts.
Receta para un dolor de rodilla: 90 píldoras de Percocet
Porque el sistema computarizado así lo indica, o por comodidad del médico, pacientes reciben pastillas extra de poderosos opioides.
Doctor’s Rx For A Stiff Knee: A Prescription For 90 Percocet Pills
Following minor surgery, KHN’s consumer columnist sees how easily doctors offer pain pills, fueling epidemic of opioid addiction.
La mayoría de los adolescentes saltean chequeos médicos de rutina
A pesar de las protecciones que ofrece la ley de salud, adolescentes pierden la posibilidad de tener diagnósticos físicos y de salud mental clave.
Despite ACA Cost Protections, Most Adolescents Skip Regular Checkups
Only 48 percent of kids ages 10 to 17 have well-child visits, even though the federal health law requires insurers to pick up the entire tab, a study finds.
Some States Roll Back ‘Retroactive Medicaid,’ A Buffer For The Poor — And For Hospitals
The retroactive payments provide protection for poor patients who can be enrolled in Medicaid after becoming seriously ill. That enrollment process takes time, and the look-back provision helps guarantee coverage they would have been entitled to if they had enrolled earlier.
Study Gives Mixed Reviews On Laws To Equalize Cancer Patients’ Out-Of-Pocket Costs
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
Past-Due Premiums, Missing Tax Forms May Hamstring Marketplace Customers
People hoping to get federal subsidized marketplace coverage may need to make sure their 2017 premiums are paid and that they filed all the correct documents with their 2016 taxes.
Millennials Embrace Nursing Profession — Just In Time To Replace Baby Boomers
Nursing generally offers stable earnings and low unemployment, which likely sounds good to young adults who came of age during the Great Recession.
Enrollment News To Bank On: Obamacare Is Still Here So It’s Time For Coverage Checkup
Open enrollment for the federal health law’s marketplace plans begin Nov. 1. In most states, the sign-up period ends Dec. 15, about six weeks sooner than past years.
Want An IUD? Take Note Of Trump’s New Birth Control Policy.
Some employers may opt to claim a religious or moral exemption and women could have to pick up some of the cost of this expensive contraception option.
Social Security Giveth, Medical Costs Taketh Away
Out-of-pocket health costs eat up about 18 percent of retirees’ incomes.
Long-Term Disability Insurance Gets Little Attention But Can Pay Off Big Time
People who become disabled because of accident, injury or illness can turn to long-term disability insurance to pay a portion of their income.
Más pacientes del Medicaid y presos podrán tratarse con una droga contra la hepatitis C
El tratamiento con una droga aprobada por la Administración de Drogas y Alimentos cuesta menos y cura la hepatitis C en alrededor de dos meses. Pacientes vulnerables tendrían más acceso a esta terapia.
Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment
The drug, sold under the name Mavyret, can cure all six genetic types of the liver disease in eight weeks at a cost of $26,400, well below other options.
Pocos se benefician con las nuevas drogas anti colesterol por el gran gasto de bolsillo
Una nueva generación de drogas podría ayudar a millones a bajar los niveles de colesterol malo. Pero el proceso para lograr una receta y el alto costo para el paciente están limitando su uso.
Out-Of-Pocket Costs Often Keep Pricey New Cholesterol Drugs Out Of Reach, Study Finds
Research published this week by JAMA Cardiology analyzed pharmacy claims data related to a new class of cholesterol-lowering drugs.
Need An MRI? Anthem Directs Most Outpatients To Independent Centers
The insurer says hospital-based imaging services are too expensive and the independent facilities provide high-quality care.
